The Europe Glycated Albumin Assay Market would witness market growth of 7.9% CAGR during the forecast period (2023-2030).
Glycemic regulation is necessary for diabetes treatment. Numerous estimations provide pointers, including glycated hemoglobin (HbA1c), 1, 5-anhydroglucitol (1,5AG), and glycated albumin. The glycemic level during the first three months of diabetes frequency is shown by glycated hemoglobin (HbA1c). For the confirmation of temporary restorative viability, while starting diabetes treatment, this test is essential.
In the near future, the market is expected to experience rapid expansion and improvements. The importance of glycated albumin testing in clinical practice is anticipated to rise due to the rising prevalence of diabetes and the requirement for efficient glycemic control monitoring. This assay has several benefits compared to conventional glycated hemoglobin (HbA1c) testing, including quicker turnaround times, sensitivity to recent glycemic alterations, and independence from variables like erythrocyte durability and specific hemoglobin variations.
Nearly one in seven UK residents are expected to be over the age of 75 by 2040, according to a government assessment titled “Future of an aging population” (UK). There will be 1.42 million more homes with a head of household who is 85 years of age or older by 2037, a rise of 161% over the previous 25 years. Over 5.5 million more people will be added to the working-age population between the ages of 50 and the state pension age (SPA), from 26% in 2012 to 34% in 2050. According to a UN assessment of France aging policy, France, like other European nations, is experiencing a steady and large rise in the population of senior people. In 2012, there were 15 million persons in France over the age of 60. In 2060, this number will increase to 24 million. It is anticipated that the market will grow as a result of the aging population in these regional nations which raise the risk of diabetes.
The Germany market dominated the Europe Glycated Albumin Assay Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $24,356.5 Thousands by 2030. The UK market is exhibiting a CAGR of 7% during (2023 - 2030). Additionally, The France market would experience a CAGR of 8.7% during (2023 - 2030).
Based on Application, the market is segmented into Type 2 Diabetes, Type 1 Diabetes, and Prediabetes. Based on End User, the market is segmented into Hospitals & Diabetic Care Center, Diagnostic Laboratory, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Glycated Albumin Assay Market is Projected to reach USD 384.5 Million by 2030, at a CAGR of 8.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Asahi Kasei Pharma Corporation (Asahi Kasei Corporation), EKF Diagnostics Holdings plc, Weldon Biotech India Private Limited, Hzymes Biotechnology Co., Ltd., Beijing Strong Biotechnologies, Inc., Diazyme Laboratories, Inc. (General Atomics), Abbexa Limited, Biomatik Corporation, Abnova Corporation and Geno Technology, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Type 2 Diabetes
- Type 1 Diabetes
- Prediabetes
By End User
- Hospitals & Diabetic Care Center
- Diagnostic Laboratory
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Asahi Kasei Pharma Corporation (Asahi Kasei Corporation)
- EKF Diagnostics Holdings plc
- Weldon Biotech India Private Limited
- Hzymes Biotechnology Co., Ltd.
- Beijing Strong Biotechnologies, Inc.
- Diazyme Laboratories, Inc. (General Atomics)
- Abbexa Limited
- Biomatik Corporation
- Abnova Corporation
- Geno Technology, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Glycated Albumin Assay Market, by Application
1.4.2 Europe Glycated Albumin Assay Market, by End User
1.4.3 Europe Glycated Albumin Assay Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Europe Glycated Albumin Assay Market by Application
4.1 Europe Type 2 Diabetes Market by Country
4.2 Europe Type 1 Diabetes Market by Country
4.3 Europe Prediabetes Market by Country
Chapter 5. Europe Glycated Albumin Assay Market by End User
5.1 Europe Hospitals & Diabetic Care Center Market by Country
5.2 Europe Diagnostic Laboratory Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Glycated Albumin Assay Market by Country
6.1 Germany Glycated Albumin Assay Market
6.1.1 Germany Glycated Albumin Assay Market by Application
6.1.2 Germany Glycated Albumin Assay Market by End User
6.2 UK Glycated Albumin Assay Market
6.2.1 UK Glycated Albumin Assay Market by Application
6.2.2 UK Glycated Albumin Assay Market by End User
6.3 France Glycated Albumin Assay Market
6.3.1 France Glycated Albumin Assay Market by Application
6.3.2 France Glycated Albumin Assay Market by End User
6.4 Russia Glycated Albumin Assay Market
6.4.1 Russia Glycated Albumin Assay Market by Application
6.4.2 Russia Glycated Albumin Assay Market by End User
6.5 Spain Glycated Albumin Assay Market
6.5.1 Spain Glycated Albumin Assay Market by Application
6.5.2 Spain Glycated Albumin Assay Market by End User
6.6 Italy Glycated Albumin Assay Market
6.6.1 Italy Glycated Albumin Assay Market by Application
6.6.2 Italy Glycated Albumin Assay Market by End User
6.7 Rest of Europe Glycated Albumin Assay Market
6.7.1 Rest of Europe Glycated Albumin Assay Market by Application
6.7.2 Rest of Europe Glycated Albumin Assay Market by End User
Chapter 7. Company Profiles
7.1 Asahi Kasei Pharma Corporation (Asahi Kasei Corporation)
7.1.1 Company Overview
7.1.2 SWOT Analysis
7.1.3 Financial Analysis
7.1.4 Segmental and Regional Analysis
7.1.5 Research & Development Expenses
7.2 EKF Diagnostics Holdings plc
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Weldon Biotech India Private Limited
7.3.1 Company Overview
7.3.2 SWOT Analysis
7.4 Hzymes Biotechnology Co., Ltd.
7.4.1 Company Overview
7.5 Beijing Strong Biotechnologies, Inc.
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 Abbexa Limited
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 Biomatik Corporation
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 Abnova Corporation
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Geno Technology, Inc.
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Diazyme Laboratories, Inc. (General Atomics)
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
7.10.3 SWOT Analysis
TABLE 1 Europe Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 2 Europe Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 3 Europe Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 4 Europe Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 5 Europe Type 2 Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 6 Europe Type 2 Diabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 7 Europe Type 1 Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 8 Europe Type 1 Diabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 9 Europe Prediabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 10 Europe Prediabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 11 Europe Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 12 Europe Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 13 Europe Hospitals & Diabetic Care Center Market by Country, 2019 - 2022, USD Thousands
TABLE 14 Europe Hospitals & Diabetic Care Center Market by Country, 2023 - 2030, USD Thousands
TABLE 15 Europe Diagnostic Laboratory Market by Country, 2019 - 2022, USD Thousands
TABLE 16 Europe Diagnostic Laboratory Market by Country, 2023 - 2030, USD Thousands
TABLE 17 Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 18 Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 19 Europe Glycated Albumin Assay Market by Country, 2019 - 2022, USD Thousands
TABLE 20 Europe Glycated Albumin Assay Market by Country, 2023 - 2030, USD Thousands
TABLE 21 Germany Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 22 Germany Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 23 Germany Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 24 Germany Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 25 Germany Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 26 Germany Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 27 UK Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 28 UK Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 29 UK Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 30 UK Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 31 UK Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 32 UK Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 33 France Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 34 France Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 35 France Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 36 France Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 37 France Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 38 France Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 39 Russia Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 40 Russia Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 41 Russia Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 42 Russia Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 43 Russia Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 44 Russia Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 45 Spain Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 46 Spain Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 47 Spain Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 48 Spain Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 49 Spain Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 50 Spain Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 51 Italy Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 52 Italy Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 53 Italy Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 54 Italy Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 55 Italy Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 56 Italy Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 57 Rest of Europe Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 58 Rest of Europe Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 59 Rest of Europe Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 60 Rest of Europe Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 61 Rest of Europe Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 62 Rest of Europe Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 63 Key Information – Asahi Kasei Pharma Corporation
TABLE 64 Key Information – EKF Diagnostics Holdings plc
TABLE 65 Key Information – Weldon Biotech India Private Limited
TABLE 66 Key Information – Hzymes Biotechnology Co., Ltd.
TABLE 67 Key Information – Beijing Strong Biotechnologies, Inc.
TABLE 68 Key Information – Abbexa Limited
TABLE 69 Key Information – Biomatik Corporation
TABLE 70 Key Information – Abnova Corporation
TABLE 71 Key Information – Geno Technology, Inc.
TABLE 72 Key Information – Diazyme Laboratories, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Glycated Albumin Assay Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting the Glycated Albumin Assay Market
FIG 4 Porter’s Five Forces Analysis – Glycated Albumin Assay Market
FIG 5 Europe Glycated Albumin Assay Market share by Application, 2022
FIG 6 Europe Glycated Albumin Assay Market share by Application, 2030
FIG 7 Europe Glycated Albumin Assay Market by Application, 2019 - 2030, USD Thousands
FIG 8 Europe Glycated Albumin Assay Market share by End User, 2022
FIG 9 Europe Glycated Albumin Assay Market share by End User, 2030
FIG 10 Europe Glycated Albumin Assay Market by End User, 2019 - 2030, USD Thousands
FIG 11 Europe Glycated Albumin Assay Market share by Country, 2022
FIG 12 Europe Glycated Albumin Assay Market share by Country, 2030
FIG 13 Europe Glycated Albumin Assay Market by Country, 2019 - 2030, USD Thousands
FIG 14 SWOT Analysis: Asahi Kasei Pharma Corporation
FIG 15 SWOT Analysis: EKF Diagnostics Holdings plc
FIG 16 SWOT Analysis: Weldon Biotech India Private Limited
FIG 17 SWOT Analysis: Beijing Strong Biotechnologies, Inc.
FIG 18 SWOT Analysis: Abbexa Limited
FIG 19 SWOT Analysis: Biomatik Corporation
FIG 20 SWOT Analysis: Abnova Corporation
FIG 21 SWOT Analysis: Geno Technology, Inc.
FIG 22 SWOT Analysis: Diazyme Laboratories, Inc.